Skip to Content


UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiviral agent

Treatment of HIV infection

HIV protease inhibitor

Chemical Names

(alphaS)-Tetrahydro-N-((alphaS)-alpha-{(2S,3S)-2-hydroxy-4-phenyl-3-[2-(2,6-dimetylphenoxy)acetamido]butyl}phenetyl)-alpha-isopropyl-2-oxopyrimidin-1(2H)-acetamid (IUPAC)

(alphaS)-Tetrahydro-N-[(alphaS)-alpha-[(2S,3S)-2-hydroxy-4-phenyl-3-[2-(2,6-xylyloxy)acetamido]butyl]phenetyl]-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide (WHO)

1(2H)-Pyrimidineacetamide, N-((1S,3S,4S)-4-(((2,6-dimetylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmetyl)pentyl)tetrahyrdo-alpha-1-metyletyl)-2-oxo-,(alphaS)-

Foreign Names

  • Lopinavirum (Latin)
  • Lopinavir (German)
  • Lopinavir (French)
  • Lopinavir (Spanish)

Generic Names

  • Lopinavir (OS: USAN, BAN, JAN)
  • A 157378.0 (IS: Abbott)
  • ABT 378 (IS: Abbott)
  • Lopinavir (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Lopinavirum (PH: Ph. Eur. 8)

Brand Names

  • Alltera (Lopinavir and Ritonavir)
    Mylan, India
  • Aluvia (Lopinavir and Ritonavir)
    Abbott, China; Abbott, Ecuador; Abbott, Indonesia; Abbott, Kenya; Abbott, Serbia; Abbott, Tanzania; Abbott, South Africa; AbbVie, Thailand; AbbVie Deutschland, Bosnia & Herzegowina; Aesica Queenborough, Macedonia
  • Kaletra (Lopinavir and Ritonavir)
    Abbott, Argentina; Abbott, Czech Republic; Abbott, Ecuador; Abbott, Greece; Abbott, Italy; Abbott, Portugal; Abbott, Romania; Abbott, Tunisia; Abbott, Taiwan; Abbott, Tanzania; Abbott, United States; Abbott, South Africa; Abbott Arzneimittel, Germany; Abbott Laboratories, Lithuania; Abbott Laboratories de Chile, Chile; AbbVie, Austria; AbbVie, Australia; AbbVie, Belgium; AbbVie, Canada; AbbVie, Switzerland; AbbVie, Germany; AbbVie, Denmark; AbbVie, Spain; AbbVie, Finland; AbbVie, France; AbbVie, United Kingdom; AbbVie, Hong Kong; AbbVie, Croatia (Hrvatska); AbbVie, Hungary; AbbVie, Ireland; AbbVie, Japan; AbbVie, Latvia; AbbVie, Netherlands; AbbVie, Norway; AbbVie, New Zealand; AbbVie, Sweden; AbbVie, Singapore; AbbVie, Thailand; AbbVie, Turkey; ABBVIE BIOPHARMACEUTICALS, Israel; Abbvie Farmacéuticos, Mexico; AbbVie Polska, Poland; AbbVie S.r.L., Slovakia; Aesica, Georgia; Cardinal Health, Oman; Changzheng-Xinkai, China
  • Lopimune (Lopinavir and Ritonavir)
    Cipla, Lebanon
  • Lopinavir/Ritonavir Accord (Lopinavir and Ritonavir)
    Accord, Netherlands
  • Lopinavir/Ritonavir Ranbaxy (Lopinavir and Lopinavir)
    Ranbaxy, Estonia
  • Lopinavir/Ritonavir Ranbaxy (Lopinavir and Ritonavir)
    Ranbaxy, Estonia
  • Lopinavir/Ritonavir Sandoz (Lopinavir and Ritonavir)
    Sandoz, Estonia; Sandoz, Netherlands
  • Loritec (Lopinavir and Ritonavir)
    Zifam India, Myanmar
  • Ritocom (Lopinavir and Ritonavir)
    Hetero, India
  • Ritomax-L (Lopinavir and Ritonavir)
    Alkem, India


BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.